P153 LIGELIZUMAB REDUCES RESCUE MEDICATION USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY RESULTS
Autor: | Sitz, K., Soong, W., Lanier, B., Kobayashi, K., Barve, A., Hua, E., Janocha, R., Severin, T. |
---|---|
Zdroj: | In Annals of Allergy, Asthma & Immunology November 2019 123(5) Supplement:S28-S28 |
Databáze: | ScienceDirect |
Externí odkaz: |